Jeeva Clinical Trials Inc

Jeeva Clinical Trials Inc Reach us to learn more about our eClinical solution.

Jeeva's virtual control room helps biopharma and medical research sponsors execute modern clinical trials end-to-end with real-time monitoring to achieve greater efficiency, minimize risks, and cut costs with one-login, one-subscription solution. Jeeva is attacking the $26B Clinical Trial Management Systems (CTMS) market to help emerging biopharma and medtech sponsors simplify, streamline, and aut

omate the clinical trial process for FDA approval. Our Unified B2B SaaS platform, powered by Agentic AI, enables real-time collaboration among sponsors, sites, clinical researchers, and patients to identify problems before they emerge. With 30+ trusted clients and paid pilots earned, Jeeva unifies CTMS, electronic data capture, digital patient recruitment, and engagement with intelligent automation, delivering 200% faster, 300% less burden, and 100% inclusivity.

Validation shouldn’t slow clinical innovation - and at Jeeva Clinical Trials, it doesn’t. Traditional validation models ...
04/16/2026

Validation shouldn’t slow clinical innovation - and at Jeeva Clinical Trials, it doesn’t.

Traditional validation models were built for static systems. But today’s AI-driven clinical operations demand something more: continuous, intelligent & compliance built into the platform itself.

That’s where our eclinical platform stand apart.

From unified architecture to AI-assisted validation, we enable:
• Continuous, risk-based validation (not periodic delays)
• Real-time audit readiness and traceability
• Faster study startups without compliance trade-offs

Aligned with evolving expectations from regulators like the FDA, EMA, and MHRA, we embed compliance directly into clinical workflows - so teams can focus on outcomes, not overhead.

The question is no longer “Are you validated?”
It’s “Is your platform continuously compliant by design?”

👉 Discover how Jeeva is redefining validation for modern clinical trials:
https://hubs.la/Q04cjZBG0

Access in Rare Disease Research is often limited by distance, fragmented systems, and low patient visibility. At Jeeva C...
04/15/2026

Access in Rare Disease Research is often limited by distance, fragmented systems, and low patient visibility.

At Jeeva Clinical Trials, we focus on removing these barriers, enabling study teams to reach the right patients, streamline operations, and maintain continuity across every stage of the trial.

This approach not only improves participation but also strengthens data quality and accelerates overall study ex*****on.

Because making research more accessible means making it work better for everyone involved.

Explore how Jeeva is enabling more accessible and connected Rare Disease Research.
🔗 https://hubs.la/Q04c7xhP0

Clinical trial pricing often feels complex because costs are spread across multiple disconnected systems and vendors. Wh...
04/10/2026

Clinical trial pricing often feels complex because costs are spread across multiple disconnected systems and vendors.

When EDC, CTMS, eCOA, eConsent, AI-assisted workflows, and patient engagement are unified in a single platform, pricing becomes clearer, more structured, and far easier to forecast.

Instead of managing separate tools and hidden overlaps, teams get full visibility into what they are actually paying for across the entire trial ecosystem.

At Jeeva, we bring these capabilities together in one connected environment, so cost clarity becomes part of the trial design itself.

💡 Estimate your trial cost instantly using the Jeeva Clinical Trials Pricing Calculator.
🔗 Use the calculator: https://hubs.la/Q04b8s7l0

AI in clinical trials isn’t limited by capability, it’s limited by infrastructure. Disconnected systems, paper burden, a...
04/08/2026

AI in clinical trials isn’t limited by capability, it’s limited by infrastructure.

Disconnected systems, paper burden, and manual workflows continue to slow down ex*****on and reduce the real value AI can deliver across studies.

Until these foundations are unified, AI cannot fully enable real-time insights, seamless workflows, or scalable trial operations.

At Jeeva, we’re building a connected, digital-first ecosystem that helps remove these bottlenecks and makes trials truly AI-ready.

💬 What’s the biggest bottleneck in your trial workflows today? Comment below.

🔗 See how Jeeva is helping build AI-ready clinical trials: https://hubs.la/Q049-LJ60

Excited to share that Harsha Karur Rajasimha, Our Founder & CEO, , along with Arianna Hiciano, our Executive Assistant w...
04/07/2026

Excited to share that Harsha Karur Rajasimha, Our Founder & CEO, , along with Arianna Hiciano, our Executive Assistant will be attending the AWS Life Sciences Symposium 2026 in New York City.

This marks a powerful opportunity to connect with visionary leaders across the life sciences ecosystem and engage in high-impact conversations around agentic AI, the future of clinical development, and the responsible adoption of emerging technologies in healthcare.

Harsha and Arianna will be actively collaborating, exchanging ideas, and building strategic relationships with innovators driving the next wave of transformation in clinical research and digital health.

At Jeeva Clinical Trials Inc., we remain committed to pioneering AI-powered, decentralized infrastructure—designed to make clinical trials more intelligent, scalable, and truly patient-centric.

Looking forward to meaningful conversations and groundbreaking collaborations ahead.

Mark your calendar:
📅 April 14, 2026
📍 Javits Center, New York

🔗 Learn more: https://hubs.la/Q049QtSD0

AI in clinical development is no longer about potential, it is about balance. As AI moves from experimentation to ex****...
04/06/2026

AI in clinical development is no longer about potential, it is about balance.

As AI moves from experimentation to ex*****on in clinical trials, the focus is shifting beyond efficiency gains to how it is governed, explained, and trusted in real-world decision-making.

From accelerating study design and patient recruitment to improving operational workflows and data insights, AI is creating measurable impact across the clinical lifecycle. But without human oversight, explainability, and ethical safeguards, these advantages can quickly become risks.

At Jeeva, we believe the real progress lies in human-guided AI, where technology enhances clinical judgment rather than replacing it.

🔍 Read the blog to explore how AI is moving from promise to practice in clinical development.
https://hubs.la/Q049GYSt0

Patient experience is not a secondary consideration in clinical trial design. It directly affects engagement, usability,...
04/03/2026

Patient experience is not a secondary consideration in clinical trial design. It directly affects engagement, usability, and data quality.

Jeeva’s eCOA approach helps study teams create a more intuitive, accessible, and connected experience for participants while supporting efficient workflows and high-quality, compliant data capture.

From device-agnostic design to AI-enabled automation and wearable integration, modern trials require infrastructure that works for both patients and study teams.

🔍 Read how Jeeva is helping redefine patient-centered trial ex*****on.
https://hubs.la/Q049b3p00

Jeeva Clinical Trials was honored to be at the University of Missouri, where Harsha Rajasimha, Ph.D., Our Founder & CEO,...
04/02/2026

Jeeva Clinical Trials was honored to be at the University of Missouri, where Harsha Rajasimha, Ph.D., Our Founder & CEO, delivered an invited guest lecture on Decentralized Clinical Trials and the evolving role of AI in transforming global research.

The session explored how decentralized models are improving patient access beyond traditional site-based constraints, while AI-enabled eClinical systems are enhancing efficiency, scalability, and data-driven decision-making.

Engaging with students, researchers, and faculty sparked meaningful dialogue on the future of clinical trials and the innovations needed to make research more patient-centric, scalable, and inclusive.

We are grateful for the opportunity to contribute to academic discourse and inspire the next generation of clinical research leaders.

Clinical trials should not lose momentum because patients cannot be physically present. As the industry shifts toward mo...
04/01/2026

Clinical trials should not lose momentum because patients cannot be physically present.

As the industry shifts toward more patient-centric models, the ability to engage participants remotely is becoming essential, not just for convenience, but for improving continuity, inclusivity, and overall trial success.

Jeeva TeleVisits & VideoVisits help study teams stay connected with participants through more flexible, accessible, and timely virtual interactions, supporting continuity, reducing friction, and making decentralized trial ex*****on more practical at scale.

When participation becomes easier, engagement improves. And when engagement improves, trials run stronger.

Explore how Jeeva helps teams deliver a more connected patient experience.
🔗 https://hubs.la/Q049b1DM0

As the Clinical Trial landscape shifts toward more connected, real-time systems, a new wave of innovation is redefining ...
03/26/2026

As the Clinical Trial landscape shifts toward more connected, real-time systems, a new wave of innovation is redefining how trials are designed and executed.

Jeeva Clinical Trials is honored to be featured by BioBuzz among 10 companies redefining how clinical trials work in real time.

This recognition reflects a broader shift from fragmented tools to connected, AI-driven systems transforming how trials are designed and managed.

At Jeeva, we are focused on rebuilding clinical research through a unified platform that brings together data, workflows, and patient engagement, enabling faster, more efficient, and patient-centric trials.

💡 As the concept of a Clinical Trial Operating System takes shape, we’re proud to be part of this transformation.

🔗 Read the full article: https://hubs.la/Q048hgy80

Jeeva Clinical Trials was proud to participate in Pharma USA 2026, held March 10–11 in Philadelphia, where Harsha Rajasi...
03/25/2026

Jeeva Clinical Trials was proud to participate in Pharma USA 2026, held March 10–11 in Philadelphia, where Harsha Rajasimha, Ph.D., our Founder & CEO, joined industry leaders, innovators, and decision-makers shaping the future of clinical research.🌐

Over the two-day summit, Harsha represented Jeeva in engaging discussions on decentralized, patient-centric trials, emerging AI-powered eClinical solutions, and strategies to simplify and accelerate global research.

These conversations sparked new collaborations and insights that will continue to guide how we innovate at Jeeva.🚀

Grateful for the meaningful connections, shared ideas, and momentum that will help drive the future of clinical trials worldwide.

Clinical trials today often rely on multiple disconnected systems, leading to operational inefficiencies, delays, and un...
03/24/2026

Clinical trials today often rely on multiple disconnected systems, leading to operational inefficiencies, delays, and unpredictable costs. For sponsors and CROs, estimating trial infrastructure expenses can become unnecessarily complex.

Jeeva is addressing this challenge with a smarter, more transparent approach to pricing. Our latest Clinical Trials Pricing Calculator is part of a unified, AI-native eClinical platform designed to bring clarity and predictability to study planning.

With integrated capabilities across EDC, CTMS, eConsent, eCOA, and patient engagement, research teams can now align technology and budgeting more effectively based on study design, participants, and duration.

Try the calculator and estimate the cost of your next study in under 2 minutes:

👉 https://hubs.la/Q047TDMs0

What’s the biggest challenge you face when estimating clinical trial infrastructure costs?

Address

10432 Balls Ford Road, Suite 300
Manassas, VA
20109

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+1 703-968-7023

Alerts

Be the first to know and let us send you an email when Jeeva Clinical Trials Inc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Jeeva Clinical Trials Inc:

Share

Jeeva Informatics Announces Emerging Focus in OMICS and Precision Medicine

Jeeva Informatics Solutions (Jeeva) (www.jeevadx.com) is excited to announce participation and exhibition with our partner DailyBreath at the inaugural total exposure health conference this week at Bethesda, MD. Meet our CEO, Dr. Harsha K Rajasimha with other key opinion leaders in this emerging area of precision medicine.

https://www.dailytelescope.com/jeeva-informatics-announces-emerging-focus-in-omics-and-precision-medicine/191582

Jeeva is a premier healthcare and life sciences informatics company with the vision to democratize precision medicine at community level. Jeeva offers expertise and solutions to engage patients as partners in clinical research from the convenience of their own home or office. Jeeva aims to accelerate biomedical research and therapies development using mobile health and bigdata platforms while reducing cost.